Stay updated with breaking news from Nasdaq evgn. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
StockNews.com began coverage on shares of Evogene (NASDAQ:EVGN – Free Report) in a report released on Wednesday. The firm issued a sell rating on the biotechnology company’s stock. Evogene Trading Down 5.0 % NASDAQ EVGN opened at $0.63 on Wednesday. The business’s fifty day moving average is $0.79 and its 200 day moving average is […]
Silverarc Capital Management LLC raised its holdings in Evogene Ltd. (NASDAQ:EVGN – Free Report) by 3,000.0% in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 3,100,000 shares of the biotechnology company’s stock after purchasing an additional 3,000,000 shares during the quarter. Silverarc Capital […]
Evogene Ltd. (NASDAQ:EVGN – Get Free Report) saw a significant decrease in short interest in December. As of December 15th, there was short interest totalling 187,200 shares, a decrease of 35.0% from the November 30th total of 287,800 shares. Based on an average daily volume of 144,100 shares, the days-to-cover ratio is presently 1.3 days. […]
Alliance Global Partners assumed coverage on shares of Evogene (NASDAQ:EVGN – Free Report) in a research report released on Monday, Marketbeat reports. The firm issued a buy rating and a $1.85 price objective on the biotechnology company’s stock. A number of other analysts have also recently issued reports on EVGN. StockNews.com began coverage on Evogene […]
Evogene (NASDAQ:EVGN – Free Report) had its target price lifted by Lake Street Capital from $2.00 to $3.00 in a research note released on Friday morning, MarketBeat.com reports. They currently have a buy rating on the biotechnology company’s stock. EVGN has been the topic of several other research reports. StockNews.com initiated coverage on Evogene in […]
Evogene (NASDAQ:EVGN – Get Free Report) announced its quarterly earnings data on Thursday. The biotechnology company reported ($0.17) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.19) by $0.02, MarketWatch Earnings reports. Evogene had a negative return on equity of 67.44% and a negative net margin of 943.25%. The firm had […]
Evogene (NASDAQ:EVGN – Get Free Report) had its price objective hoisted by equities researchers at Lake Street Capital from $2.00 to $3.00 in a research note issued to investors on Friday, FlyOnTheWall reports. Lake Street Capital’s price objective would indicate a potential upside of 372.81% from the company’s current price. A number of other equities […]
Stock analysts at StockNews.com initiated coverage on shares of Evogene (NASDAQ:EVGN – Get Free Report) in a research report issued to clients and investors on Monday. The firm set a “sell” rating on the biotechnology company’s stock. Several other equities analysts also recently weighed in on the stock. Roth Mkm lifted their price target on […]
Evogene Ltd. (NASDAQ:EVGN – Get Rating)’s stock price crossed below its two hundred day moving average during trading on Tuesday . The stock has a two hundred day moving average of $0.68 and traded as low as $0.61. Evogene shares last traded at $0.65, with a volume of 132,598 shares. Analyst Upgrades and Downgrades Separately, […]
Evogene Ltd. (NASDAQ:EVGN – Get Rating) saw a significant growth in short interest in May. As of May 15th, there was short interest totalling 288,700 shares, a growth of 13.4% from the April 30th total of 254,500 shares. Based on an average daily volume of 73,300 shares, the short-interest ratio is currently 3.9 days. Currently, […]